The role of histone modifications in the development of metabolic dysfunction-associated steatotic liver disease
Loading...
Date
Authors
Aleksandrova, Tetiana
Vizir, Maryna
Zhelezniakova, Natalia
Journal Title
Journal ISSN
Volume Title
Publisher
Sumy State University
Editor(s)
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive spectrum of liver diseases that begins with liver steatosis, followed by metabolic dysfunction-associated steatohepatitis (MASH) and may progress to liver fibrosis. The underlying mechanisms of MASLD are multifaceted and involve both genetic and non-genetic (epigenetic) factors.
Description
Citation
Aleksandrova T. The role of histone modifications in the development of metabolic dysfunction-associated steatotic liver disease / T. Aleksandrova, M. Vizir, N. Zhelezniakova // Biomedical Perspectives VI : Abstract book of International Medical Conference of Students, Postgraduates and Young Scientists, Sumy, April 23─24, 2026. – Sumy : Sumy State University, 2026. – P. 102.